Back to search

Article

Antisense oligonucleotide therapy for the common Stargardt disease type 1-causing variant in <i>ABCA4</i>

2022-08-12

Abstract excerpt

<h4>ABSTRACT</h4> The c.5461-10T>C p.[Thr1821Aspfs*6,Thr1821Valfs*13] variant has been identified as the most common severe Stargardt disease type 1 (STGD1)-associated variant in ABCA4 . STGD1 is the most recurrent hereditary form of maculopathy and so far, no treatment is available for STGD1. In STGD1 patients homozygous for this variant, the onset of the disease typically is in childhood and patients are legal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b81470eb-cb5c-5ac1-beeb-029fae83b5d4
DOI
10.1101/2022.08.12.503728
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antisense oligonucleotide therapy for the common Stargardt disease type 1-causing variant in <i>ABCA4</i>DOI 10.1101/2022.08.12.503728
Select a neighboring publication to make it the new centre.